Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Johnson Matthey (JMAT.L)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (p) Price Target (p) Rating
2021-01-2229952050Sell
2021-01-2730102150Sell
2021-03-0832232300Sell
2021-04-1431152500Sell
2021-05-2830462700Sell
2021-10-1327062500Sell
2021-11-2620662000Sell
2022-01-1819391875Sell
2022-04-0419321800Sell
2022-05-3021311950Sell
2022-07-1420521750Sell
2022-12-1320922100Neutral
2023-03-2819362000Neutral
2023-06-0717971900Neutral
2023-11-1015401700Neutral
2023-11-2215331650Neutral
2024-04-1917881950Neutral

Disclosures

  • UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS beneficially owned 1% or more of a class of this company`s common equity securities as of last month`s end (or the prior month`s end if this report is dated less than 10 days after the most recent month`s end).
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.